1Asada Y ,Sumiyoshi A, Hayashi T, et al. Immunochemistry of vascular lesions in thrombotic thrombocytopenic purpura,with special reference to factor ⅤⅢ related antigen[J]. Throms Res, 1985,38 : 469 - 479. 被引量：1
2Moake JL,Rudy CK,Troll JH,et al. Unusually large plasma factor Ⅷ: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura [J]. N Engl J Med, 1982,307: 1432 -1435 被引量：1
3Furlan M, Robles R, Lamie B. Partial purification and characterization of a protease from human plasma cleaving yon Willebrand factor to fragments produced by in vivo proteolysis [ J ]. Blood, 1996, 87:4223 - 4234. 被引量：1
4Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calciumion[J]. Blood, 1996,87(10) :4235 -4244. 被引量：1
1Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest,1985,76:2178-2181. 被引量：1
2Dvorak HF, Brown LF, Detmar M,et al. Vaseular permeability factor/vascular endothelial growth factor, mierovascular hyperpermeability and angiogenesis. Am J Path, 1995,146 : 1029-1039. 被引量：1
3Yoo G, Blomback M, Schenck-Gustafsson K,et al, Decreased levels of yon Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura:study of a simplified method for assaying the enzynme activity based on restoeetin-induced platelet aggregation. Br J Hemato1,2003,121 : 123-129. 被引量：1
4Wada H, Kaneko T, Ohiwa M,et al, Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol, 1993,44 : 101-105. 被引量：1
5Kim J,Wu H, Hawthorne L,et al. Endothelial cell apoptotic genes associated with the pathogenesis of thrombotic mivroangiopathies: an application of oligonucleotide genechip technology. Microvas Res, 2001,62,83-93. 被引量：1
6Chou C, Jajeh A, Shiomoto G,et al. Schistocvtes in normal individuals. Blood, 1998, 92:4b. 被引量：1
8Allford SL,Hunt BJ,Rose P,et al.Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.Br J Haematol,2003,120(4):556-573. 被引量：1
9Caramazza D,Quintini G,Abbene I,et al.Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome.Blood Transfus,2010,8(3):203-210. 被引量：1
10Asamiya Y,Moriyama T,Takano M,et al.Successful treatment with rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis.Intern Med,2010,49(15):1587-1591. 被引量：1
